Skip to content

Oculis Holding AG

OCS · XNAS

CIK 1953530fmd_05VH66ZTGJTE69VQSCYTJ93T43Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2020 to Dec 31, 2025, 9 periods

Latest annual · FY2025

Millions
Operating income
(82)
Net income
(99)
Free cash flow
(67)

Latest quarter · Q2 FY2025

Millions
Operating income
(21)
Net income
(25)

Daily close · OCSIEX trades only

Nov 13, 2025 to Nov 11, 2026 · 250 sessions

7.61 USD

010203040Nov 13, 2025May 14, 2026Nov 11, 2026Vol

Built from trades executed at IEX only, one exchange with a small share of US volume. This is not the consolidated tape. The close is the last IEX trade of the session, not the official closing price. Earlier sessions are divided by the later split ratios the API confirmed against IEX prices; dividends are not adjusted. Switch to As traded for the prices as they printed. End of day, not real time: a session is published the day after it trades.

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms

Open Financials

Key stats

Open Analysis

Compound annual growth

Net income, 5 yearsFY2020 to FY2025
n/m

Oculis Holding AG (OCS) financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2025FY2024ChangeSource
Operating income-CHF 81.7 million-CHF 73.2 million20-F 2026-03-04 · proof
Net income-CHF 99 million-CHF 85.8 million20-F 2026-03-04 · proof
Cash from operating activities-CHF 66.3 million-CHF 48.9 million20-F 2026-03-04 · proof
Free cash flow-CHF 66.6 million-CHF 49.1 million20-F 2026-03-04 · proof
Total assetsCHF 236 millionCHF 120.4 million+96.1%20-F 2026-03-04 · proof
Total liabilitiesCHF 39.9 millionCHF 47 million-15.1%20-F 2026-03-04 · proof
Cash and cash equivalentsCHF 81.3 millionCHF 27.7 million+193.5%20-F 2026-03-04 · proof
What was Oculis Holding AG (OCS)'s operating income in fiscal 2025?
Oculis Holding AG (OCS) reported operating income of -CHF 81.7 million for fiscal 2025 (the year ended Dec 31, 2025), against -CHF 73.2 million the year before. Source: the 20-F filed with the SEC on Mar 4, 2026. SEC
What was Oculis Holding AG (OCS)'s net income in fiscal 2025?
Oculis Holding AG (OCS) reported net income of -CHF 99 million for fiscal 2025 (the year ended Dec 31, 2025), against -CHF 85.8 million the year before. Source: the 20-F filed with the SEC on Mar 4, 2026. SEC
What was Oculis Holding AG (OCS)'s cash from operating activities in fiscal 2025?
Oculis Holding AG (OCS) reported cash from operating activities of -CHF 66.3 million for fiscal 2025 (the year ended Dec 31, 2025), against -CHF 48.9 million the year before. Source: the 20-F filed with the SEC on Mar 4, 2026. SEC
What was Oculis Holding AG (OCS)'s free cash flow in fiscal 2025?
Oculis Holding AG (OCS) reported free cash flow of -CHF 66.6 million for fiscal 2025 (the year ended Dec 31, 2025), against -CHF 49.1 million the year before. Source: the 20-F filed with the SEC on Mar 4, 2026. SEC
What are Oculis Holding AG (OCS)'s total assets?
As of Dec 31, 2025, Oculis Holding AG (OCS) reported total assets of CHF 236 million, against CHF 120.4 million a year earlier (+96.1%). Source: the 20-F filed with the SEC on Mar 4, 2026. SEC
What are Oculis Holding AG (OCS)'s total liabilities?
As of Dec 31, 2025, Oculis Holding AG (OCS) reported total liabilities of CHF 39.9 million, against CHF 47 million a year earlier (-15.1%). Source: the 20-F filed with the SEC on Mar 4, 2026. SEC
What are Oculis Holding AG (OCS)'s cash and cash equivalents?
As of Dec 31, 2025, Oculis Holding AG (OCS) reported cash and cash equivalents of CHF 81.3 million, against CHF 27.7 million a year earlier (+193.5%). Source: the 20-F filed with the SEC on Mar 4, 2026. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:OCS&period_type=annual&limit=5"

Information only, not investment advice.